Autoimmune Diseases  >>  AMG 108  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AMG 108 / AstraZeneca
NCT00293826: A Multiple Dose Study to Evaluate Subcutaneous AMG 108 in Subjects With Rheumatoid Arthritis

Completed
2
813
US
AMG 108, Placebo
Amgen
Rheumatoid Arthritis
11/07
02/08
NCT00369473: Long-Term Assessment of Safety and Physical Function With AMG 108 in RA

Completed
2
690
US
AMG 108
Amgen
Rheumatoid Arthritis
06/08
06/08

Download Options